Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Co-Diagnostics, Inc. (CODX : NSDQ)

• Company Description    Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. Number of Employees: 132

• Price / Volume Information    Yesterday's Closing Price: $0.17 Daily Weekly Monthly 20 Day Moving Average: 1,807,153 shares Shares Outstanding: 60.89 (millions) Market Capitalization: $10.27 (millions) Beta: 1.25 52 Week High: $32.10 52 Week Low: $4.84 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -56.38% -56.30% 12 Week -60.79% -61.42% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2401 S. FOOTHILL DRIVE SUITE D - SALT LAKE CITY,UT 84109 USA ph: 801-438-1036 fax: - investors@codiagnostics.com http://www.codiagnostics.com

• General Corporate Information    Officers Dwight Egan - Chief Executive Officer; President and Director Brian Brown - Chief Financial Officer Eugene Durenard - Director Edward Murphy - Director James Nelson - Director Peer Information Co-Diagnostics, Inc. (CHCR) Co-Diagnostics, Inc. (ESRX) Co-Diagnostics, Inc. (MYDP) Co-Diagnostics, Inc. (COR) Co-Diagnostics, Inc. (GBCS) Co-Diagnostics, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 189763105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/26/26 Share - Related Items Shares Outstanding: 60.89 Most Recent Split Date: (:1) Beta: 1.25 Market Capitalization: $10.27 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.12 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.36 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/26/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.26 Price/Cash Flow: - Price / Sales: 20.25 EPS Growth vs. Year Ago Period: 50.00% vs. Previous Quarter: 30.43% Sales Growth vs. Year Ago Period: -77.38% vs. Previous Quarter: -11.04% ROE 12/31/25 - - 09/30/25 - -70.26 06/30/25 - -69.49 ROA 12/31/25 - - 09/30/25 - -61.19 06/30/25 - -60.49 Current Ratio 12/31/25 - - 09/30/25 - 3.81 06/30/25 - 4.12 Quick Ratio 12/31/25 - - 09/30/25 - 3.51 06/30/25 - 3.83 Operating Margin 12/31/25 - - 09/30/25 - -6,347.34 06/30/25 - -3,588.24 Net Margin 12/31/25 - - 09/30/25 - -6,347.34 06/30/25 - -3,588.33 Pre-Tax Margin 12/31/25 - - 09/30/25 - -6,574.36 06/30/25 - -3,584.55 Book Value 12/31/25 - - 09/30/25 - 0.65 06/30/25 - 1.23 Inventory Turnover 12/31/25 - - 09/30/25 - 0.31 06/30/25 - 0.54 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©